• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    EXECUTIVE CHAIRMAN Krantz Jason Ronald was granted 153,847 shares, increasing direct ownership by 16% to 1,125,157 units (SEC Form 4)

    4/7/25 4:25:59 PM ET
    $DH
    Computer Software: Prepackaged Software
    Technology
    Get the next $DH alert in real time by email
    SEC FORM 4 SEC Form 4
    FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0287
    Estimated average burden
    hours per response: 0.5
      
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
      
    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
    1. Name and Address of Reporting Person*
    Krantz Jason Ronald

    (Last) (First) (Middle)
    C/O DEFINITIVE HEALTHCARE CORP.
    492 OLD CONNECTICUT PATH, SUITE 401

    (Street)
    FRAMINGHAM MA 01701

    (City) (State) (Zip)
    2. Issuer Name and Ticker or Trading Symbol
    Definitive Healthcare Corp. [ DH ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    X Director X 10% Owner
    Officer (give title below) X Other (specify below)
    EXECUTIVE CHAIRMAN
    3. Date of Earliest Transaction (Month/Day/Year)
    04/03/2025
    4. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V Amount (A) or (D) Price
    Class A Common Stock 04/03/2025 A 153,847(1) A $0 1,125,157 D
    Class A Common Stock 450,000 I See footnote(2)
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
    Explanation of Responses:
    1. Represents restricted stock units ("RSUs"), each representing a contingent right to receive one share of the Issuer's Class A Common Stock, par value $0.001, with 100% of the RSUs vesting on April 1, 2026, subject to the Reporting Person's continued service with the Issuer through each such vesting date.
    2. Amount beneficially owned in trust by DH Holdings (fka Jason R. Krantz 2009 Trust), of which the Reporting Person is the beneficiary.
    /s/ Matthew Ruderman, Attorney-in-Fact 04/07/2025
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $DH alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $DH

    DatePrice TargetRatingAnalyst
    5/9/2025Buy → Neutral
    BTIG Research
    1/13/2025$4.00Equal Weight → Underweight
    Barclays
    12/20/2024$5.00Equal-Weight
    Stephens
    9/17/2024$7.00Buy
    BTIG Research
    7/31/2024$7.00 → $5.00Neutral → Underweight
    JP Morgan
    5/8/2024$11.50 → $9.00Overweight → Equal-Weight
    Morgan Stanley
    1/17/2024Buy → Hold
    Needham
    1/5/2024Buy → Hold
    Canaccord Genuity
    More analyst ratings

    $DH
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Definitive Healthcare Reports Financial Results for First Quarter Fiscal Year 2025

      FRAMINGHAM, Mass., May 08, 2025 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. ("Definitive Healthcare" or the "Company") (NASDAQ:DH), an industry leader in healthcare commercial intelligence, today announced financial results for the quarter ended March 31, 2025.  First Quarter 2025 Financial Highlights: Revenue was $59.2 million, a decrease of 7% from $63.5 million in Q1 2024. Net Loss, inclusive of goodwill impairment charges of $176.5 million, was $(155.1) million, or (262)% of revenue, compared to $(12.7) million or (20)% of revenue in Q1 2024.  Adjusted Net Income was $7.0 million, compared to $13.0 million in Q1 2024.   Adjusted EBITDA was $14.7 million, or 25% of revenue, compar

      5/8/25 4:05:00 PM ET
      $DH
      Computer Software: Prepackaged Software
      Technology
    • Definitive Healthcare Announces Timing of Its First Quarter 2025 Financial Results Conference Call and Webcast

      FRAMINGHAM, Mass., April 24, 2025 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. ("Definitive Healthcare") (NASDAQ:DH), an industry leader in healthcare commercial intelligence, today announced that it will report financial results for its first quarter ended March 31, 2025, on Thursday, May 8, 2025 after market close. The company will host a conference call and webcast at 5:00 PM (ET) / 2:00 PM (PT) to discuss the company's financial results. A live audio webcast of the event will be available on the Definitive Healthcare's Investor Relations website at https://ir.definitivehc.com/. A live dial-in will be available at 877-358-7298 (domestic) or +1-848-488-9244 (international). Shortly

      4/24/25 4:05:00 PM ET
      $DH
      Computer Software: Prepackaged Software
      Technology
    • Definitive Healthcare Corp. reports inducement grants under Nasdaq Listing Rule 5635(c)(4)

      FRAMINGHAM, Mass., April 04, 2025 (GLOBE NEWSWIRE) -- Definitive Healthcare (NASDAQ:DH), an industry leader in healthcare commercial intelligence, today announced that in connection with the hiring of one senior leader, the Human Capital Management and Compensation Committee (the "Committee") of Definitive Healthcare's Board of Directors granted inducement awards. The Committee granted Jeff Moyer, Definitive Healthcare's new SVP of Growth and Sales Operations, an inducement award consisting of 364,432 time-based restricted stock units ("RSUs"), effective April 3, 2025. These awards were individually negotiated and granted as an inducement material to Mr. Moyer's respective commencement of

      4/4/25 8:00:00 AM ET
      $DH
      Computer Software: Prepackaged Software
      Technology

    $DH
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Definitive Healthcare downgraded by BTIG Research

      BTIG Research downgraded Definitive Healthcare from Buy to Neutral

      5/9/25 8:41:31 AM ET
      $DH
      Computer Software: Prepackaged Software
      Technology
    • Definitive Healthcare downgraded by Barclays with a new price target

      Barclays downgraded Definitive Healthcare from Equal Weight to Underweight and set a new price target of $4.00

      1/13/25 7:41:23 AM ET
      $DH
      Computer Software: Prepackaged Software
      Technology
    • Stephens initiated coverage on Definitive Healthcare with a new price target

      Stephens initiated coverage of Definitive Healthcare with a rating of Equal-Weight and set a new price target of $5.00

      12/20/24 7:31:03 AM ET
      $DH
      Computer Software: Prepackaged Software
      Technology

    $DH
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • CHIEF FINANCIAL OFFICER Booth Richard Douglas covered exercise/tax liability with 7,873 shares, decreasing direct ownership by 1% to 652,630 units (SEC Form 4)

      4 - Definitive Healthcare Corp. (0001861795) (Issuer)

      5/5/25 4:30:10 PM ET
      $DH
      Computer Software: Prepackaged Software
      Technology
    • EXECUTIVE CHAIRMAN Krantz Jason Ronald covered exercise/tax liability with 18,795 shares, decreasing direct ownership by 2% to 1,106,362 units (SEC Form 4)

      4 - Definitive Healthcare Corp. (0001861795) (Issuer)

      5/5/25 4:30:14 PM ET
      $DH
      Computer Software: Prepackaged Software
      Technology
    • CHIEF OPERATING OFFICER Shamsuddin Kate Marie covered exercise/tax liability with 4,595 shares, decreasing direct ownership by 0.65% to 699,902 units (SEC Form 4)

      4 - Definitive Healthcare Corp. (0001861795) (Issuer)

      5/5/25 4:30:11 PM ET
      $DH
      Computer Software: Prepackaged Software
      Technology

    $DH
    Leadership Updates

    Live Leadership Updates

    See more
    • Definitive Healthcare Appoints Kevin Coop as CEO for Next Phase of Company's Growth

      FRAMINGHAM, Mass., May 28, 2024 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. ("Definitive Healthcare") (NASDAQ:DH), an industry leader in healthcare commercial intelligence, today announced that its Board of Directors has appointed Kevin Coop as the Company's next Chief Executive Officer and as a member of the Board of Directors, each effective June 24, 2024. Mr. Coop succeeds Jason Krantz, founder and Executive Chairman, who has been serving as Interim CEO since January 2024. Mr. Krantz will continue to serve on the Board of Directors as Executive Chairman after the CEO transition. "Kevin is an outstanding leader. He has deep, hands-on experience with data-focused businesses and has a

      5/28/24 8:00:00 AM ET
      $DH
      Computer Software: Prepackaged Software
      Technology
    • Established Executive and Milwaukee Business Leader Jim Emling Joins VBA as Executive Chair of the Board of Directors

      Jim Emling, the CEO of Datassential and former long-time president of Milwaukee-based Zywave, has been appointed Executive Chair of the Board of Directors at VBA, the company announced today. "We are delighted to welcome Jim officially to VBA as the Executive Chair," said Michael Clayton, the company's President and CEO. "Jim and I have worked closely together over the last 3 months and his decades of experience scaling high growth software companies combined with his strong ties to the Milwaukee technology sector will be tremendous assets to VBA as we enter our next phase of growth." Emling has deep roots in the Milwaukee technology community. He was the founding CTO of Zywave and serv

      11/28/23 5:00:00 PM ET
      $DH
      $GDRX
      Computer Software: Prepackaged Software
      Technology
      EDP Services
    • Definitive Healthcare Names Carrie Lazorchak as Chief Revenue Officer

      FRAMINGHAM, Mass., Oct. 05, 2023 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (NASDAQ:DH), an industry leader in healthcare commercial intelligence, today announced that Carrie Lazorchak has been named Chief Revenue Officer, effective November 1, 2023. "I am thrilled to welcome Carrie Lazorchak to Definitive Healthcare as our new Chief Revenue Officer," said Robert Musslewhite, Chief Executive Officer of Definitive Healthcare. "Carrie is a fantastic fit for Definitive Healthcare. Her values and her deep belief in the power of humble collaboration make her a perfect match for our culture. Carrie brings a wealth of experience selling Software as a Service to both enterprise accounts and

      10/5/23 4:05:00 PM ET
      $DH
      Computer Software: Prepackaged Software
      Technology

    $DH
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G filed by Definitive Healthcare Corp.

      SC 13G - Definitive Healthcare Corp. (0001861795) (Subject)

      11/12/24 11:54:03 AM ET
      $DH
      Computer Software: Prepackaged Software
      Technology
    • SEC Form SC 13G filed by Definitive Healthcare Corp.

      SC 13G - Definitive Healthcare Corp. (0001861795) (Subject)

      10/3/24 9:08:57 PM ET
      $DH
      Computer Software: Prepackaged Software
      Technology
    • SEC Form SC 13G/A filed by Definitive Healthcare Corp. (Amendment)

      SC 13G/A - Definitive Healthcare Corp. (0001861795) (Subject)

      2/14/24 4:00:33 PM ET
      $DH
      Computer Software: Prepackaged Software
      Technology

    $DH
    Financials

    Live finance-specific insights

    See more
    • Definitive Healthcare Reports Financial Results for First Quarter Fiscal Year 2025

      FRAMINGHAM, Mass., May 08, 2025 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. ("Definitive Healthcare" or the "Company") (NASDAQ:DH), an industry leader in healthcare commercial intelligence, today announced financial results for the quarter ended March 31, 2025.  First Quarter 2025 Financial Highlights: Revenue was $59.2 million, a decrease of 7% from $63.5 million in Q1 2024. Net Loss, inclusive of goodwill impairment charges of $176.5 million, was $(155.1) million, or (262)% of revenue, compared to $(12.7) million or (20)% of revenue in Q1 2024.  Adjusted Net Income was $7.0 million, compared to $13.0 million in Q1 2024.   Adjusted EBITDA was $14.7 million, or 25% of revenue, compar

      5/8/25 4:05:00 PM ET
      $DH
      Computer Software: Prepackaged Software
      Technology
    • Definitive Healthcare Announces Timing of Its First Quarter 2025 Financial Results Conference Call and Webcast

      FRAMINGHAM, Mass., April 24, 2025 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. ("Definitive Healthcare") (NASDAQ:DH), an industry leader in healthcare commercial intelligence, today announced that it will report financial results for its first quarter ended March 31, 2025, on Thursday, May 8, 2025 after market close. The company will host a conference call and webcast at 5:00 PM (ET) / 2:00 PM (PT) to discuss the company's financial results. A live audio webcast of the event will be available on the Definitive Healthcare's Investor Relations website at https://ir.definitivehc.com/. A live dial-in will be available at 877-358-7298 (domestic) or +1-848-488-9244 (international). Shortly

      4/24/25 4:05:00 PM ET
      $DH
      Computer Software: Prepackaged Software
      Technology
    • Definitive Healthcare Reports Financial Results for Fourth Quarter and Full Fiscal Year 2024

      FRAMINGHAM, Mass., Feb. 27, 2025 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. ("Definitive Healthcare" or the "Company") (NASDAQ:DH), an industry leader in healthcare commercial intelligence, today announced financial results for the quarter and full year ended December 31, 2024.  Fourth Quarter 2024 Financial Highlights: Revenue was $62.3 million, a decrease of 6% from $65.9 million in Q4 2023. Net Loss, inclusive of goodwill impairment charges of $97.1 million, was $(84.7) million, or (136)% of revenue, compared to $(13.4) million or (20)% of revenue in Q4 2023.  Adjusted Net Income was $12.6 million, compared to $10.6 million in Q4 2023.   Adjusted EBITDA was $17.5 million, or 28%

      2/27/25 4:05:53 PM ET
      $DH
      Computer Software: Prepackaged Software
      Technology

    $DH
    SEC Filings

    See more
    • SEC Form 10-Q filed by Definitive Healthcare Corp.

      10-Q - Definitive Healthcare Corp. (0001861795) (Filer)

      5/8/25 4:22:09 PM ET
      $DH
      Computer Software: Prepackaged Software
      Technology
    • Definitive Healthcare Corp. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

      8-K - Definitive Healthcare Corp. (0001861795) (Filer)

      5/8/25 4:10:28 PM ET
      $DH
      Computer Software: Prepackaged Software
      Technology
    • SEC Form DEFA14A filed by Definitive Healthcare Corp.

      DEFA14A - Definitive Healthcare Corp. (0001861795) (Filer)

      4/23/25 4:17:22 PM ET
      $DH
      Computer Software: Prepackaged Software
      Technology